Every Form 4 that The Vita Coco Company, Inc. (COCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow COCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full COCO filings page.
Vita Coco Company, Inc. (COCO) reported that Chief Operating Officer Jonathan Burth had 10,801 shares of common stock disposed of on August 15, 2026 at $65.21 per share. A footnote states these shares were withheld to cover tax withholding obligations upon RSU vesting and were mandated by the issuer. Following this tax-withholding disposition, Burth directly holds 47,109 common shares and retains multiple non-qualified stock option awards over COCO common stock with exercise prices between $10.178 and $33.36, expiring from 2030 through 2035.
Vita Coco Company, Inc. (COCO) reported that Chief Commercial Officer Charles van Es had 10,801 shares of common stock withheld on August 15, 2026 at $65.21 per share to satisfy tax withholding obligations arising from the vesting and settlement of Restricted Stock Units. The related footnote explains this disposition was mandated by the issuer and was not a discretionary trade by the reporting person. After this withholding, van Es directly held 48,284 shares of common stock.
In addition, van Es continues to hold several Non-Qualified Stock Options (Right to Buy) over Vita Coco common stock, including options exercisable at $10.178, $15.00, $15.36, $16.91, $26.18, and $33.36 per share with expiration dates ranging from 2030 to 2035. Footnotes describe these options as either fully vested, vesting in scheduled annual installments, or having vesting tied to specified performance conditions that have been met for certain tranches.
Vita Coco Company, Inc. (COCO) reported that Chief Marketing Officer Jane Prior had 10,801 shares of common stock withheld on August 15, 2026 to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The shares, valued at $65.21 per share, were disposed of as a mandated, non‑discretionary transaction required by the company. After this tax‑withholding event, Prior directly held 115,780 shares of Vita Coco common stock. She also holds several non‑qualified stock option awards on common stock, with exercise prices ranging from $10.178 to $33.36 per share and expirations between 2031 and 2035, covering various underlying share amounts as reported.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $82.916 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, he holds 580,296 common shares directly, plus a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Vita Coco Company, Inc. director Ira Liran reported two open-market sales of common stock on June 12, 2026. One sale was 73,842 shares at a weighted average price of $80.322 per share, with trades ranging from $77.40 to $81.42. The other was 74,232 shares at a weighted average price of $80.292, within the same price range.
The filing notes these transactions were executed under a pre-arranged Rule 10b5-1 trading plan. After the sales, Liran’s reported holdings total 402,579 shares held indirectly through family trusts and 309,871 shares held directly, leaving him with about 712,450 shares overall.
Vita Coco Company, Inc. director Ira Liran reported selling 191,926 shares of Common Stock in open-market transactions. The shares were sold at a weighted average price of about $79.14 per share under a Rule 10b5-1 trading plan. After these trades, he holds 384,103 shares directly and 476,421 shares indirectly through the Ira Liran 2012 Family Trust and the Ira Liran Revocable Trust.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an option-related share sale. He exercised stock options to acquire a total of 30,000 shares of common stock at an exercise price of $10.178 per share, then sold 30,000 shares at $80.00 per share in an open-market transaction.
The filing states that the stock sales were made under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Burth directly holds 57,910 shares of Vita Coco common stock and retains multiple non-qualified stock option awards with various exercise prices and expiration dates.
Liran Ira reported acquisition or exercise transactions in this Form 4 filing.
Vita Coco Company, Inc. director Liran Ira reported a compensation-related stock grant rather than an open-market trade. He received 1,530 restricted stock units (RSUs) of common stock at a reference price of $75.18 per share under the company's 2021 Incentive Award Plan.
The RSUs vest in full on the earlier of the day immediately before the next annual stockholders meeting after the grant date or the first anniversary of the grant date, if he remains in continuous service. After this grant, Ira holds 479,871 shares directly and 572,579 shares indirectly through the Ira Liran 2012 Family Trust.
Vita Coco Company, Inc. director Jane Cecil Morreau received an equity grant of 1,530 shares of Common Stock on June 3, 2026, reported as deferred RSUs that will vest in full before the next annual stockholders meeting or on the first anniversary of the grant date, subject to continued board service. Following this grant, she directly holds 18,709 Common shares. She also holds a fully vested, currently exercisable non-qualified stock option covering 30,500 Common shares at an exercise price of $10.178 per share, expiring on July 12, 2031.
Vita Coco Company, Inc. director Kenneth Sadowsky reported a routine equity compensation grant. He received 1,530 shares of Common Stock as deferred restricted stock units (RSUs) that vest in full on the earlier of the day before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as he remains in continuous service. These deferred RSUs will settle on June 3, 2031, with each unit delivering one share of common stock. After this grant, Sadowsky directly holds 584,196 shares of Common Stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of Common Stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Dozie Aishetu Fatima reported acquisition or exercise transactions in this Form 4 filing.
Vita Coco Company, Inc. director Dozie Aishetu Fatima reported receiving an award of 1,530 shares of common stock on 2026-06-03 as a compensation grant. The filing prices the grant at $75.18 per share. Following this award, she directly holds 16,376 shares of Vita Coco common stock.
According to the footnote, the grant represents deferred restricted stock units under the company’s 2021 Incentive Award Plan. These units vest in full on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided she continues serving on the board. The deferred RSUs will settle in shares when she ceases service on the board, with each unit delivering one share of Vita Coco common stock.
Vita Coco Company, Inc. director John Zupo reported an equity compensation grant and his current holdings. He received 1,530 deferred restricted stock units (RSUs), each representing one share of common stock, granted under the company’s 2021 Incentive Award Plan. These RSUs vest in full on the earlier of the day immediately preceding the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, provided he remains in continuous service, and will settle on June 3, 2031. Following this grant, he holds 13,692 shares of common stock directly. He also holds a fully vested, currently exercisable non-qualified stock option covering 20,675 shares of common stock at an exercise price of $10.178 per share, expiring on December 16, 2029.
Vita Coco Company, Inc. director Shelley G. Broader received a grant of 1,530 shares of common stock in the form of restricted stock units (RSUs) valued at $75.18 per share. After this equity award, her directly held common stock position reported in this filing is 2,050 shares.
The RSUs were granted under the company’s 2021 Incentive Award Plan and vest in full on the earlier of the day immediately before the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as she remains in continuous service. Each RSU converts into one share of Vita Coco common stock when it vests.
Vita Coco Company, Inc. director Eric Melloul received an equity grant of 1,530 shares of common stock in the form of restricted stock units (RSUs). The award was valued at $75.18 per share for reporting purposes and increased his direct holdings to 4,816 shares.
The RSUs were granted under the company’s 2021 Incentive Award Plan and will vest in full on the earlier of the day immediately preceding the next Annual Stockholders Meeting after the grant date or the first anniversary of the grant date, as long as he remains in continuous service. Each RSU converts into one share of common stock when it vests.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 8,045 shares of common stock at $75.05 per share, executed under a Rule 10b5-1 trading plan. After this sale, he directly holds 59,085 common shares.
He also holds several non-qualified stock options to buy common stock, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates from 2030 to 2035, reflecting a continuing equity-based position in the company.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock on May 20, 2026 at a weighted average price of $77.475 per share. The sale was executed under a Rule 10b5-1 trading plan.
After this transaction, Sadowsky directly owned 582,666 shares of Vita Coco common stock. He also held a fully vested, currently exercisable non-qualified stock option covering 27,300 shares at an exercise price of $10.178 per share, expiring on January 2, 2030.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an exercise-and-sale transaction in company stock. He exercised 30,000 shares of Common Stock at an exercise price of $10.178 per share through a non-qualified stock option and on the same date sold 30,000 shares in an open-market transaction at $75.00 per share. The sales were effected under a Rule 10b5-1 trading plan, indicating they were pre-arranged. Following these transactions, he directly holds 57,910 shares of Common Stock and retains multiple outstanding stock option awards, including options linked to 40,950 underlying shares at an exercise price of $10.178 expiring on February 10, 2030 and options linked to 34,125 underlying shares at an exercise price of $10.178 expiring on January 11, 2031.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported an exercise-and-sale transaction in company stock. He exercised stock options to acquire 20,000 shares of Common Stock at $10.178 per share, then sold 20,000 shares at $70.00 per share in an open-market transaction.
The sale was made under a Rule 10b5-1 trading plan, indicating it was pre-arranged rather than opportunistic. After the reported sale, Burth directly holds 57,910 shares of Common Stock. He also retains multiple outstanding non-qualified stock option awards with exercise prices ranging from $10.178 to $33.36 and expirations between 2030 and 2035, some of which vest over time or upon meeting performance conditions.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 8,561 shares of common stock at $70.0000 per share. After this transaction, he directly holds 67,130 shares of common stock.
The sale was effected under a Rule 10b5-1 trading plan, indicating it was pre-arranged. Van Es also continues to hold multiple non-qualified stock options to buy common stock, with exercise prices between $10.1780 and $33.3600 and expiration dates from 2030 through 2035.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of Common Stock at $66.87 per share. Following this sale, he directly holds 75,691 Common Stock shares. The filing also lists multiple outstanding non-qualified stock options that are vested or scheduled to vest over time, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates extending through 2035. A footnote states the sale was executed under a pre-arranged Rule 10b5-1 trading plan.
Vita Coco Company, Inc. director and Executive Chairman Michael Kirban reported an insider transaction involving a trust he is associated with. On the reported date, the Michael Kirban Revocable Trust sold 50,000 shares of common stock at $68.00 per share in an open‑market transaction carried out under a Rule 10b5‑1 trading plan. Following this sale, that revocable trust held 515,681 shares of Vita Coco common stock. Separately, the filing shows 1,479,049 shares of common stock held indirectly by the Michael Kirban 2010 Trust and 143,799 shares held directly, along with several blocks of non‑qualified stock options with exercise prices ranging from $10.178 to $32.78 per share and expirations between 2029 and 2035.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth executed an exercise-and-sell trading pattern under a Rule 10b5-1 trading plan. On April 29–30, 2026, he exercised options to acquire 60,000 shares of common stock at an exercise price of about $10.178 per share and sold 60,000 shares in open-market transactions at prices ranging from $62.50 to $67.50 per share. Following these transactions, he directly owns 57,910 shares of common stock and retains several non-qualified stock option awards with exercise prices between $10.178 and $33.36 per share expiring between 2030 and 2035.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an exercise-and-sell transaction in company stock. He exercised stock options to acquire a total of 45,544 shares of common stock at an exercise price of $10.178 per share, then sold the same 45,544 shares in open-market transactions on two days at weighted average prices of $51.13 and $59.348 per share.
The filing states that these sales were effected under a Rule 10b5-1 trading plan. Following the transactions, Roper directly holds 298,484 shares of common stock. The filing also lists indirect holdings in shares held by his spouse and several Exempt Family Trusts, as well as multiple remaining non-qualified stock option awards with exercise prices ranging from $10.178 to $32.78 and expirations extending to 2035.
Vita Coco Company, Inc. Chief Executive Officer Martin Roper reported a series of option exercises and share sales in company stock. On April 24 and April 27, he exercised stock options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share and sold 50,000 shares of common stock in open-market transactions at $50.00 per share. Following these transactions, he directly holds 298,484 shares of common stock, with additional indirect holdings reported by his spouse and several Exempt Family Trusts. The filing notes that the sales under these transactions were effected pursuant to a Rule 10b5-1 trading plan, indicating they were pre-scheduled under a pre-arranged trading program.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an option exercise and related share sale. He exercised a non-qualified stock option to acquire 25,000 shares of common stock at $10.178 per share, then sold 25,000 shares of common stock at $50.00 per share in an open-market transaction effected under a Rule 10b5-1 trading plan.
Following these transactions, he directly holds 298,484 shares of common stock and retains multiple non-qualified stock options over additional shares with exercise prices between $10.178 and $32.78 expiring between 2031 and 2035. He also has indirect ownership of common stock through the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts and through his spouse.
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold shares in a planned set of trades. He exercised 25,000 non-qualified stock options at an exercise price of $10.178 per share on each of two days, receiving 50,000 shares of common stock.
On those same days he sold 25,000 shares at $50.00 and 25,000 shares at a weighted average price of $50.107, with actual sale prices ranging from $50.00 to $50.30, under a Rule 10b5-1 trading plan. After these transactions, he directly owns 298,484 common shares and continues to hold multiple option awards with exercise prices between $10.178 and $32.780, as well as indirect holdings through family trusts and his spouse.
Vita Coco Company, Inc. director Kenneth Sadowsky sold shares in a pre-planned trade. He sold 3,900 shares of common stock on April 15, 2026 in an open-market sale at a weighted average price of $48.93 per share under a Rule 10b5-1 trading plan.
After this sale, he directly owns 586,566 common shares and holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares at an exercise price of $10.178 per share, expiring on January 2, 2030.
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold the resulting shares. He exercised options for 29,456 shares of common stock at an exercise price of $10.178 per share, then sold 29,456 shares in open-market trades at weighted average prices around $50-$51.10 under a Rule 10b5-1 trading plan. After these transactions, he directly holds 298,484 common shares, alongside additional indirect holdings through family trusts and his spouse.
Vita Coco Company, Inc. chief executive Martin Roper exercised stock options and sold shares in coordinated transactions. On April 7 and 8, he exercised options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share, then sold 50,000 shares in open-market trades at weighted average prices of approximately $50.00 and $50.949 per share. After these transactions, he directly holds 298,484 common shares and retains multiple blocks of non-qualified stock options with exercise prices ranging from $10.178 to $32.780 per share. The sales were made under a pre-arranged Rule 10b5-1 trading plan.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock on April 1, 2026 at $48.67 per share. The sale was effected under a Rule 10b5-1 trading plan.
Following this sale, he directly owns 77,691 shares of common stock. He also holds multiple non-qualified stock options to buy Vita Coco common stock, with exercise prices ranging from $10.178 to $33.36 per share and expiration dates between 2030 and 2035.
Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported an open‑market sale of 2,000 shares of common stock on March 19, 2026 at an average price of $55.45 per share. The sale was executed under a Rule 10b5‑1 trading plan, indicating it was pre‑scheduled rather than a discretionary trade.
After this transaction, Baker directly holds 25,951 common shares. He also holds several non‑qualified stock options to acquire additional Vita Coco common shares, with exercise prices ranging from $16.91 to $33.36 and expiration dates between 2033 and 2035.
Vita Coco Company, Inc.’s Chief Financial Officer Corey Baker reported open-market sales of company common stock. On March 17, 2026, he sold 2,000 shares at $59.92 per share, followed by another 2,000 shares at $58.04 per share on March 18, 2026, for total reported sales of 4,000 shares.
After these transactions, Baker directly holds 27,951 shares of common stock. He also holds multiple non-qualified stock options to purchase additional common shares with exercise prices ranging from $16.91 to $33.36. The filing notes that the stock sales were carried out under a Rule 10b5-1 trading plan, indicating they were pre-arranged.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 3,900 shares of common stock at a weighted average price of $56.918 per share. The trade was executed pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating it was scheduled in advance.
After the sale, Sadowsky directly holds 590,466 shares of common stock. He also holds a fully vested, currently exercisable non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth exercised options for 40,000 shares of common stock at an exercise price of $10.178 per share and sold 60,000 shares in open-market transactions on March 16, 2026 at prices ranging from $57.98 to $60.00. The sales were effected under a Rule 10b5-1 trading plan.
Following these transactions, Burth holds 57,910 shares of common stock directly. He also retains multiple option awards, including non-qualified stock options exercisable for 40,950 underlying shares at an exercise price of $10.178 per share expiring on February 10, 2030, along with additional options at higher exercise prices and later expiration dates.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported an open-market sale of 2,000 shares of common stock at $57.98 per share on March 16, 2026. The filing notes these sales were effected under a Rule 10b5-1 trading plan.
After the transaction, van Es directly holds 79,691 shares of common stock. He also holds several non-qualified stock options to buy additional Vita Coco shares, including grants exercisable at $10.178 per share expiring on February 10, 2030 and January 11, 2031, and higher-priced options expiring through March 4, 2035.
Vita Coco Company, Inc.’s Chief Financial Officer, Corey Baker, reported open‑market sales of 4,000 shares of common stock. The trades occurred on March 13, 2026 and March 16, 2026, with 2,000 shares sold at $58.86 and 2,000 shares at $57.98 per share.
After these transactions, Baker directly holds 31,951 shares of Vita Coco common stock. He also holds several non‑qualified stock options, including awards over 9,205 shares at $16.91 expiring on March 10, 2033 and 13,481 shares at $24.35 expiring on May 10, 2033. The sales were made under a pre‑arranged Rule 10b5‑1 trading plan.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 10,000 shares of common stock on March 16, 2026 at a weighted average price of $60.137 per share. The sale was effected under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, Sadowsky directly holds 594,366 shares of Vita Coco common stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Vita Coco Company, Inc. Executive Chairman Michael Kirban, through the Michael Kirban Revocable Trust, sold 50,000 shares of common stock in open-market transactions at $58 per share on March 11–12, 2026 under a Rule 10b5-1 trading plan. Following these sales, the filing shows continued indirect ownership of 565,681 shares in that trust, additional indirect holdings in the Michael Kirban 2010 Trust, direct ownership of common stock, and multiple fully vested and time-vesting stock options covering substantial additional shares.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported a mandated tax-withholding disposition of 818 shares of common stock on March 11, 2026, at a price of $54.91 per share. The shares were withheld by the company to cover tax obligations from vesting and settlement of restricted stock units and were not a discretionary transaction.
After this event, Burth directly owns 77,910 shares of common stock. He also holds multiple non-qualified stock options on common stock with exercise prices ranging from $10.178 to $33.36 and expiration dates between 2029 and 2035, reflecting a continuing equity position.
Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported share dispositions that were used solely to cover tax withholding obligations. On March 11, 2026, a total of 5,226 shares of common stock were withheld at $54.91 per share in three mandated tax-withholding transactions related to restricted stock unit vesting. Following these transactions, Baker directly holds 35,951 shares of common stock. He also holds several non-qualified stock options over additional common shares with exercise prices between $16.91 and $33.36, expiring between 2033 and 2035.
Vita Coco Company, Inc. Chief Marketing Officer Jane Prior reported a routine share disposition related to equity compensation. On the reported date, 818 shares of common stock were withheld at $54.91 per share to cover tax obligations from vesting and settlement of Restricted Stock Units. The footnotes state this withholding was mandated by the issuer and was not a discretionary transaction by the executive.
After this tax-withholding event, Prior directly holds 126,581 shares of common stock. She also holds several non-qualified stock options to buy additional common shares at exercise prices ranging from $10.178 to $33.36, with expiration dates between 2031 and 2035, many of which vest over time or are already exercisable.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es had 818 shares of Common Stock withheld at $54.91 per share to satisfy tax withholding obligations from Restricted Stock Unit vesting. According to the disclosure, this disposition was mandated by the company and was not a discretionary trade. After the tax withholding, he directly holds 81,691 Common shares, along with several Non-Qualified Stock Options, including a fully vested option covering 53,750 underlying shares at an exercise price of $10.178 that expires in 2030.
Vita Coco Company, Inc. Chief Marketing Officer Jane Prior reported a mix of option exercises, tax withholdings, and sales of common stock. On March 5, 2026, she exercised stock options to acquire a total of 50,000 shares of common stock at an exercise price of $10.178 per share in multiple transactions.
On the same date, she disposed of 1,458 and 705 shares of common stock at $55.175 per share to satisfy tax withholding obligations tied to restricted stock unit vesting; this withholding was mandated by the company and was not a discretionary transaction. She also sold 34,159, 15,741, and 100 shares of common stock in open-market transactions at weighted average prices of $52.73, $53.32, and $54.08 per share, respectively, under a Rule 10b5-1 trading plan.
Following these transactions, she directly owned 127,399 shares of common stock. Separately, on February 20, 2026, performance conditions were satisfied for a stock option covering 14,025 shares, causing that option to vest, and she holds several other non-qualified stock options with specified time-based vesting schedules.
Vita Coco Company, Inc. Chief Operating Officer Jonathan Burth reported routine equity-related transactions. On March 5, 2026, he disposed of 1,458 and 705 shares of common stock at $55.175 per share to cover tax withholding obligations tied to vesting Restricted Stock Units; this disposition was mandated by the company and was not a discretionary sale. After these transactions, he held 78,728 common shares directly. On February 20, 2026, he was granted a non-qualified stock option for 14,025 shares at an exercise price of $16.91 after specified performance conditions were satisfied, resulting in vesting of that option grant.
Vita Coco Company, Inc. Executive Chairman Michael Kirban reported a disposition of 5,810 shares of common stock on March 5, 2026, to cover tax withholding obligations tied to vesting Restricted Stock Units. The shares were withheld at a price of $55.175 per share, and the transaction was mandated by the issuer, not a discretionary sale by Kirban.
After this tax-withholding event, Kirban directly holds 143,799 shares of Vita Coco common stock. He also has indirect ownership through trusts, including 1,479,049 shares held by the Michael Kirban 2010 Trust and 615,681 shares held by the Michael Kirban Revocable Trust. In addition, he holds several non-qualified stock option grants, with one grant fully vested and exercisable and others vesting in four equal annual installments beginning on November 27, 2022, March 10, 2024, March 4, 2025, and March 3, 2026.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported a disposition of common stock that was used to cover tax withholding on vested Restricted Stock Units. On March 5, 2026, 5,363 shares of common stock were withheld at $55.175 per share, leaving him with 298,484 directly held shares. The filing notes this tax-withholding disposition was mandated by the company and was not a discretionary transaction by Roper. He also reports indirect ownership of common stock through exempt family trusts for Christopher, Peter, and Thomas Roper, and through his spouse, plus several fully vested or time-vesting non-qualified stock options.
Vita Coco Company, Inc. Chief Financial Officer Corey Baker reported mandatory share dispositions tied to equity compensation. On March 5, 2026, 1,327 and 651 shares of common stock were withheld at $55.175 per share to satisfy tax obligations from Restricted Stock Unit vesting, a process mandated by the company rather than a discretionary sale. The filing also updates several non-qualified stock option positions that vest in staged annual installments beginning on dates including March 10, 2024, March 4, 2025, and extending through March 10, 2027.
Vita Coco Company, Inc. Chief Commercial Officer Charles van Es reported routine equity-related transactions. On March 5, 2026, a total of 1,458 and 705 shares of common stock were disposed of at $55.175 per share to cover tax withholding obligations upon Restricted Stock Unit vesting, a disposition mandated by the issuer and not a discretionary sale.
On February 20, 2026, van Es was granted a non-qualified stock option covering 14,025 shares at an exercise price of $16.91 per share after specified performance conditions were satisfied, causing that portion to vest. Additional option footnotes describe various grants that vest in equal annual installments over three or four years, contingent on continued service.
Vita Coco Company, Inc. Executive Chairman Michael Kirban reported a tax-related share disposition. On March 4, 2026, 3,965 shares of common stock were withheld at $54.12 per share to cover tax obligations from vesting Restricted Stock Units, a disposition mandated by the company and not a discretionary trade. He continues to hold 149,609 common shares directly, plus additional shares indirectly through the Michael Kirban 2010 Trust and the Michael Kirban Revocable Trust.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an automatic share disposition tied to equity compensation. On March 4, 2026, 3,660 shares of common stock were withheld at $54.12 per share to cover tax obligations from vesting Restricted Stock Units, a disposition mandated by the issuer rather than a discretionary sale.
Following this tax-withholding event, Roper directly holds 303,847 shares of common stock. He also reports multiple holdings of Non-Qualified Stock Options and Performance Options, some fully vested and others vesting in four equal annual installments beginning on November 27, 2022, March 10, 2024, March 4, 2025, and March 3, 2026. Additional common shares are indirectly held through the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts and by his spouse.